← Leaderboards
Daniel Delubac
Xilis, Inc.
$1,396,992
Attributed
$1,396,992
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $998.5K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,396,992 · 1
By mechanism
R44$1,396,992 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Automation”
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Judith Doherty$11,781,802
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Jennifer Wierman · Cornell University$7,750,000
- Paola A Ramos · Mayo Clinic Rochester$7,298,203
- Travis Henry · Mayo Clinic Rochester$6,835,150
Research focus
AutomationAdoptionBiologyBiopsyBreast Cancer DetectionBreast Cancer PatientBreast Cancer TherapyCancer DiagnosticsCancer PatientCancer TherapyCancer TypeCaringCellsClinicClinical DataClinical DiagnosticsClinical Laboratory Improvement AmendmentsClinical PredictorsClinical ProtocolsClinical ResearchCommercializationComplexCostData Integration
Grant awards (2)
Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy$998,506
R44 · FY2023 · CA · contact PI
Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy$398,486
R44 · FY2022 · CA · contact PI